Field effectiveness of vaccination against tick-borne encephalitis
Abstract Tick-borne encephalitis (TBE) is a vaccine-preventable disease caused by a flavivirus (TBE virus) that is endemic in many European countries and large parts of Central and Eastern Asia. In Europe, highly purified formalin-inactivated whole virus vaccines are in widespread use, but the vacci...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2007-10, Vol.25 (43), p.7559-7567 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7567 |
|---|---|
| container_issue | 43 |
| container_start_page | 7559 |
| container_title | Vaccine |
| container_volume | 25 |
| creator | Heinz, Franz X Holzmann, Heidemarie Essl, Astrid Kundi, Michael |
| description | Abstract Tick-borne encephalitis (TBE) is a vaccine-preventable disease caused by a flavivirus (TBE virus) that is endemic in many European countries and large parts of Central and Eastern Asia. In Europe, highly purified formalin-inactivated whole virus vaccines are in widespread use, but the vaccination coverage differs significantly between countries with TBE endemicity. Austria presents an exceptional situation because 88% of the total population have a history of TBE vaccination, with 58% being regularly vaccinated within the recommended schedule. In this study, we investigated the field effectiveness of TBE vaccination in Austria for the years 2000–2006 in different age groups on the basis of the documented numbers of hospitalized cases in unvaccinated and vaccinated people and the sizes of these population groups as revealed by representative inquiries. We show that the overall effectiveness in regularly vaccinated persons is about 99% with no statistically significant difference between age groups. It is at least as high after the first two vaccinations, i.e. before the completion of the basic vaccination scheme by a third vaccination, but is significantly lower (about 95%) in those with a record of irregular vaccination. Our data confirm the excellent performance of TBE vaccine under field conditions and provide evidence that, in Austria, about 2800 cases were prevented by vaccination in the years 2000–2006. |
| doi_str_mv | 10.1016/j.vaccine.2007.08.024 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68358493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X07009474</els_id><sourcerecordid>3419462571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-d5942ecb45e20ae693c8bed54392e1b29cc7e4264b9d9a65d3ba38ed0bda6c3c3</originalsourceid><addsrcrecordid>eNqFkkFv1DAQhS1ERZeWnwCKhOgtYRzbiX0BQUUpUiUOFImb5dgT8DbrbO3sSv33ddhIK_XS01y-eTPz3hDylkJFgTYf19XeWOsDVjVAW4GsoOYvyIrKlpW1oPIlWUHd8JJT-HNKXqe0BgDBqHpFTmkrG8WkWpGvVx4HV2Dfo538HgOmVIx9cRA3kx9DYf4aH9JUTN7eld0YAxYYLG7_mcFPPp2Tk94MCd8s9Yz8vvp2e3ld3vz8_uPyy01pRcum0gnFa7QdF1iDwTzfyg6d4EzVSLtaWdsizxt3yinTCMc6wyQ66JxpLLPsjFwcdLdxvN9hmvTGJ4vDYAKOu6QbyYTkij0LUpU9YZxn8P0TcD3uYshHaCqEbBVtOWRKHCgbx5Qi9nob_cbEB01Bz1notV6y0HMWGqTOWeS-d4v6rtugO3Yt5mfgwwKYZM3QRxOsT0dOUaHkf6HPBw6zu3uPUSfr5wScjzk17Ub_7CqfnijYwQefh97hA6bj1TrVGvSv-XHmv4EWQPGWs0eOSb7h</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1558791740</pqid></control><display><type>article</type><title>Field effectiveness of vaccination against tick-borne encephalitis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Heinz, Franz X ; Holzmann, Heidemarie ; Essl, Astrid ; Kundi, Michael</creator><creatorcontrib>Heinz, Franz X ; Holzmann, Heidemarie ; Essl, Astrid ; Kundi, Michael</creatorcontrib><description>Abstract Tick-borne encephalitis (TBE) is a vaccine-preventable disease caused by a flavivirus (TBE virus) that is endemic in many European countries and large parts of Central and Eastern Asia. In Europe, highly purified formalin-inactivated whole virus vaccines are in widespread use, but the vaccination coverage differs significantly between countries with TBE endemicity. Austria presents an exceptional situation because 88% of the total population have a history of TBE vaccination, with 58% being regularly vaccinated within the recommended schedule. In this study, we investigated the field effectiveness of TBE vaccination in Austria for the years 2000–2006 in different age groups on the basis of the documented numbers of hospitalized cases in unvaccinated and vaccinated people and the sizes of these population groups as revealed by representative inquiries. We show that the overall effectiveness in regularly vaccinated persons is about 99% with no statistically significant difference between age groups. It is at least as high after the first two vaccinations, i.e. before the completion of the basic vaccination scheme by a third vaccination, but is significantly lower (about 95%) in those with a record of irregular vaccination. Our data confirm the excellent performance of TBE vaccine under field conditions and provide evidence that, in Austria, about 2800 cases were prevented by vaccination in the years 2000–2006.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2007.08.024</identifier><identifier>PMID: 17869389</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age ; Allergy and Immunology ; Animals ; Applied microbiology ; Arboviral encephalitis ; Arboviroses ; Austria - epidemiology ; Biological and medical sciences ; Child ; Child, Preschool ; Encephalitis ; Encephalitis Viruses, Tick-Borne - immunology ; Encephalitis, Tick-Borne - epidemiology ; Encephalitis, Tick-Borne - immunology ; Encephalitis, Tick-Borne - prevention & control ; Flavivirus ; Fundamental and applied biological sciences. Psychology ; Human viral diseases ; Humans ; Immunization Programs - legislation & jurisprudence ; Immunization Programs - organization & administration ; Immunization Schedule ; Infant ; Infant, Newborn ; Infectious diseases ; Laboratories ; Medical sciences ; Medical statistics ; Microbiology ; Middle Aged ; Tick-borne encephalitis (TBE) ; Treatment Outcome ; Tropical viral diseases ; Vaccination - methods ; Vaccination coverage ; Vaccine effectiveness ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vaccines, Inactivated - administration & dosage ; Vaccines, Inactivated - immunology ; Viral diseases ; Viral Vaccines - administration & dosage ; Viral Vaccines - immunology ; Viruses</subject><ispartof>Vaccine, 2007-10, Vol.25 (43), p.7559-7567</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Oct 23, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-d5942ecb45e20ae693c8bed54392e1b29cc7e4264b9d9a65d3ba38ed0bda6c3c3</citedby><cites>FETCH-LOGICAL-c573t-d5942ecb45e20ae693c8bed54392e1b29cc7e4264b9d9a65d3ba38ed0bda6c3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X07009474$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19159824$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17869389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heinz, Franz X</creatorcontrib><creatorcontrib>Holzmann, Heidemarie</creatorcontrib><creatorcontrib>Essl, Astrid</creatorcontrib><creatorcontrib>Kundi, Michael</creatorcontrib><title>Field effectiveness of vaccination against tick-borne encephalitis</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Tick-borne encephalitis (TBE) is a vaccine-preventable disease caused by a flavivirus (TBE virus) that is endemic in many European countries and large parts of Central and Eastern Asia. In Europe, highly purified formalin-inactivated whole virus vaccines are in widespread use, but the vaccination coverage differs significantly between countries with TBE endemicity. Austria presents an exceptional situation because 88% of the total population have a history of TBE vaccination, with 58% being regularly vaccinated within the recommended schedule. In this study, we investigated the field effectiveness of TBE vaccination in Austria for the years 2000–2006 in different age groups on the basis of the documented numbers of hospitalized cases in unvaccinated and vaccinated people and the sizes of these population groups as revealed by representative inquiries. We show that the overall effectiveness in regularly vaccinated persons is about 99% with no statistically significant difference between age groups. It is at least as high after the first two vaccinations, i.e. before the completion of the basic vaccination scheme by a third vaccination, but is significantly lower (about 95%) in those with a record of irregular vaccination. Our data confirm the excellent performance of TBE vaccine under field conditions and provide evidence that, in Austria, about 2800 cases were prevented by vaccination in the years 2000–2006.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Applied microbiology</subject><subject>Arboviral encephalitis</subject><subject>Arboviroses</subject><subject>Austria - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Encephalitis</subject><subject>Encephalitis Viruses, Tick-Borne - immunology</subject><subject>Encephalitis, Tick-Borne - epidemiology</subject><subject>Encephalitis, Tick-Borne - immunology</subject><subject>Encephalitis, Tick-Borne - prevention & control</subject><subject>Flavivirus</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunization Programs - legislation & jurisprudence</subject><subject>Immunization Programs - organization & administration</subject><subject>Immunization Schedule</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infectious diseases</subject><subject>Laboratories</subject><subject>Medical sciences</subject><subject>Medical statistics</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Tick-borne encephalitis (TBE)</subject><subject>Treatment Outcome</subject><subject>Tropical viral diseases</subject><subject>Vaccination - methods</subject><subject>Vaccination coverage</subject><subject>Vaccine effectiveness</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vaccines, Inactivated - administration & dosage</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Viral diseases</subject><subject>Viral Vaccines - administration & dosage</subject><subject>Viral Vaccines - immunology</subject><subject>Viruses</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkkFv1DAQhS1ERZeWnwCKhOgtYRzbiX0BQUUpUiUOFImb5dgT8DbrbO3sSv33ddhIK_XS01y-eTPz3hDylkJFgTYf19XeWOsDVjVAW4GsoOYvyIrKlpW1oPIlWUHd8JJT-HNKXqe0BgDBqHpFTmkrG8WkWpGvVx4HV2Dfo538HgOmVIx9cRA3kx9DYf4aH9JUTN7eld0YAxYYLG7_mcFPPp2Tk94MCd8s9Yz8vvp2e3ld3vz8_uPyy01pRcum0gnFa7QdF1iDwTzfyg6d4EzVSLtaWdsizxt3yinTCMc6wyQ66JxpLLPsjFwcdLdxvN9hmvTGJ4vDYAKOu6QbyYTkij0LUpU9YZxn8P0TcD3uYshHaCqEbBVtOWRKHCgbx5Qi9nob_cbEB01Bz1notV6y0HMWGqTOWeS-d4v6rtugO3Yt5mfgwwKYZM3QRxOsT0dOUaHkf6HPBw6zu3uPUSfr5wScjzk17Ub_7CqfnijYwQefh97hA6bj1TrVGvSv-XHmv4EWQPGWs0eOSb7h</recordid><startdate>20071023</startdate><enddate>20071023</enddate><creator>Heinz, Franz X</creator><creator>Holzmann, Heidemarie</creator><creator>Essl, Astrid</creator><creator>Kundi, Michael</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20071023</creationdate><title>Field effectiveness of vaccination against tick-borne encephalitis</title><author>Heinz, Franz X ; Holzmann, Heidemarie ; Essl, Astrid ; Kundi, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-d5942ecb45e20ae693c8bed54392e1b29cc7e4264b9d9a65d3ba38ed0bda6c3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Applied microbiology</topic><topic>Arboviral encephalitis</topic><topic>Arboviroses</topic><topic>Austria - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Encephalitis</topic><topic>Encephalitis Viruses, Tick-Borne - immunology</topic><topic>Encephalitis, Tick-Borne - epidemiology</topic><topic>Encephalitis, Tick-Borne - immunology</topic><topic>Encephalitis, Tick-Borne - prevention & control</topic><topic>Flavivirus</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunization Programs - legislation & jurisprudence</topic><topic>Immunization Programs - organization & administration</topic><topic>Immunization Schedule</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infectious diseases</topic><topic>Laboratories</topic><topic>Medical sciences</topic><topic>Medical statistics</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Tick-borne encephalitis (TBE)</topic><topic>Treatment Outcome</topic><topic>Tropical viral diseases</topic><topic>Vaccination - methods</topic><topic>Vaccination coverage</topic><topic>Vaccine effectiveness</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vaccines, Inactivated - administration & dosage</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Viral diseases</topic><topic>Viral Vaccines - administration & dosage</topic><topic>Viral Vaccines - immunology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heinz, Franz X</creatorcontrib><creatorcontrib>Holzmann, Heidemarie</creatorcontrib><creatorcontrib>Essl, Astrid</creatorcontrib><creatorcontrib>Kundi, Michael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heinz, Franz X</au><au>Holzmann, Heidemarie</au><au>Essl, Astrid</au><au>Kundi, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Field effectiveness of vaccination against tick-borne encephalitis</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2007-10-23</date><risdate>2007</risdate><volume>25</volume><issue>43</issue><spage>7559</spage><epage>7567</epage><pages>7559-7567</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract Tick-borne encephalitis (TBE) is a vaccine-preventable disease caused by a flavivirus (TBE virus) that is endemic in many European countries and large parts of Central and Eastern Asia. In Europe, highly purified formalin-inactivated whole virus vaccines are in widespread use, but the vaccination coverage differs significantly between countries with TBE endemicity. Austria presents an exceptional situation because 88% of the total population have a history of TBE vaccination, with 58% being regularly vaccinated within the recommended schedule. In this study, we investigated the field effectiveness of TBE vaccination in Austria for the years 2000–2006 in different age groups on the basis of the documented numbers of hospitalized cases in unvaccinated and vaccinated people and the sizes of these population groups as revealed by representative inquiries. We show that the overall effectiveness in regularly vaccinated persons is about 99% with no statistically significant difference between age groups. It is at least as high after the first two vaccinations, i.e. before the completion of the basic vaccination scheme by a third vaccination, but is significantly lower (about 95%) in those with a record of irregular vaccination. Our data confirm the excellent performance of TBE vaccine under field conditions and provide evidence that, in Austria, about 2800 cases were prevented by vaccination in the years 2000–2006.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17869389</pmid><doi>10.1016/j.vaccine.2007.08.024</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2007-10, Vol.25 (43), p.7559-7567 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68358493 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Age Allergy and Immunology Animals Applied microbiology Arboviral encephalitis Arboviroses Austria - epidemiology Biological and medical sciences Child Child, Preschool Encephalitis Encephalitis Viruses, Tick-Borne - immunology Encephalitis, Tick-Borne - epidemiology Encephalitis, Tick-Borne - immunology Encephalitis, Tick-Borne - prevention & control Flavivirus Fundamental and applied biological sciences. Psychology Human viral diseases Humans Immunization Programs - legislation & jurisprudence Immunization Programs - organization & administration Immunization Schedule Infant Infant, Newborn Infectious diseases Laboratories Medical sciences Medical statistics Microbiology Middle Aged Tick-borne encephalitis (TBE) Treatment Outcome Tropical viral diseases Vaccination - methods Vaccination coverage Vaccine effectiveness Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Inactivated - administration & dosage Vaccines, Inactivated - immunology Viral diseases Viral Vaccines - administration & dosage Viral Vaccines - immunology Viruses |
| title | Field effectiveness of vaccination against tick-borne encephalitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Field%20effectiveness%20of%20vaccination%20against%20tick-borne%20encephalitis&rft.jtitle=Vaccine&rft.au=Heinz,%20Franz%20X&rft.date=2007-10-23&rft.volume=25&rft.issue=43&rft.spage=7559&rft.epage=7567&rft.pages=7559-7567&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2007.08.024&rft_dat=%3Cproquest_cross%3E3419462571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1558791740&rft_id=info:pmid/17869389&rft_els_id=S0264410X07009474&rfr_iscdi=true |